Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Insulin and Insulin-related Characteristics, and Short-Term Low-glycemic and High-glycemic Carbohydrate Intervention on Breast Cancer Biomarkers and Survival

NCT03886389 is registered in ClinicalTrials.gov with Helse Stavanger HF as lead sponsor.

NCT NCT03886389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03886389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Insulin and Insulin-related Characteristics, and Short-Term Low-glycemic and High-glycemic Carbohydrate Intervention on Breast Cancer Biomarkers and Survival
Lead sponsor
Helse Stavanger HF
Phase
Not applicable
Overall status
Completed
Start date
June 12, 2009
Completion date
July 7, 2017
Enrollment
80 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

carbohydrate engorgement, early-stage breast cancer, estrogen receptor-positive breast cancer, insulin resistance, proliferation